The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Filimonova G.N.

Acad. G.A. Ilizarov Russian Center for Restorative Traumatology and Orthopedics, Ministry of Health of Russia, Kurgan, Russia

Migalkin N.S.

Acad. G.A. Ilizarov Russian Center for Restorative Traumatology and Orthopedics, Ministry of Health of Russia, Kurgan, Russia

Morphological characteristics of paravertebral muscles in patients with scoliosis caused by primaryprogressive muscular dystrophies (in Russian only)

Authors:

Filimonova G.N., Migalkin N.S.

More about the authors

Read: 8048 times


To cite this article:

Filimonova GN, Migalkin NS. Morphological characteristics of paravertebral muscles in patients with scoliosis caused by primaryprogressive muscular dystrophies (in Russian only). Russian Journal of Archive of Pathology. 2019;81(3):45‑50. (In Russ.)
https://doi.org/10.17116/patol20198103145

Recommended articles:
Clinical Case of HIV-Associated Kaposi’s Sarcoma. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(6):782-786

References:

  1. Gusev EI, Nikiforov AS. General neurology (Obshchaya nevrologiya). Moscow: GEOTAR-Media, 2007. (In Russ.)
  2. Sewry CA. Muscular dystrophies: an update on pathology and diagnosis. Acta Neuropathol. 2010;120(3):343-358. https://doi.org/10.1007/s00401-010-0727-5
  3. Zhdanova EB, Kharlamov DA, Belousov ED. Somatic disorders in progressive Duchenne dystrophy. Rossiiskiy vestnik perinatologii i pediatrii. 2011;5:46-50. (In Russ.)
  4. Gecht BM, Il’ina NA. Neuro-muscular diseases (Nervno-myshechnye bolezni). Moscow: Meditsina, 1998. (In Russ.)
  5. Petrov A, Laoudj D, Vasetskiĭ E. Genetics and epigenetics of fascio-scapulohumeral progressive Landouzy—Dejerine) muscular dystrophy. Genetika. 2003;39(2):202-206. (In Russ.)
  6. Elikbaev GM, Khachatryan VA, Osipov IB. Epidemiology and early diagnosis of congenital malformations of the spine and spinal cord. Voprosy sovremennoi pediatrii. 2008;4:58-62. (In Russ.)
  7. Grebennikova IN, Ryzhkov II, Repalova NV, Es’kova EV, Tambovtseva IV. The method of integral assessment of the bioelectrical activity of paravertebral muscles in the early diagnosis of impaired posture in the differential diagnosis of scoliosis. Vestnik gil’dii protezistov-ortopedov. 2006;2:45-50. (In Russ.)
  8. Dadali EL, Sharkova IV, Ugarov IV. Neuromuscular — clinical portraits. Accessed 09.11.2017. Available at: https://www.neuromuscular.iugarov.com Last update: 17.07.2010
  9. Neuromuscular disease center. Washington University, St. Louis, MO USA. September 2016. Acceessed 02.06.2018. Available at: https://neuromuscular.wustl.edu/index.html
  10. Avakyan GN, Gekht AB, Nikiforov AS. Rational pharmacotherapy in neurology. A guide for practitioners. (Ratsional’naya farmakoterapiya v nevrologii. Rukovodstvo dlya praktikuyushchikh vrachei). Litterra; 2018. (In Russ.)
  11. Feldman E, Grisold V, Russell J. Atlas of neuromuscular diseases. A practical guideline. Lesher V. Prakticheskaya meditsina; 2016. (In Russ.)
  12. Antelava OA, Kasatkina LF, Gurkina GT, Radenska-Lopovok SG, Khitrov AN, Stutman VZ, Nasonov EL. Differential diagnosis of muscle weakness (Differentsial’naya diagnostika myshechnoi slabosti). RMZh. 2004;12(14):854-862. Accessed Jule 8, 2018. (In Russ.). Available at:] https:www.medicusamicus.com
  13. Foidart M, Foidart JM, Engel WK. Collagen localization in normal and fibrotic human skeletal muscle. Arch Neurol. 1981;38(3):152-157.
  14. Stephen CC. Channelopathies of skeletal muscle excitability. Compr Physiol. 2015;5(2):761-790. https://doi.org/10.1002/cphy.c140062
  15. Evtushenko SK, Shaimurzin MR, Evtushenko IS. New modern technologies in the treatment of neuromuscular diseases, aimed at slowing their progression (Novye sovremennye tekhnologii v terapii neiromyshechnykh zabolevanii, napravlennye na zamedlenie ikh progressirovaniya). Mezhdunarodnyi nevrologicheskii zhurnal. 2009;4:9-19. (In Russ.)
  16. Matthews E, Brassington R, Kuntzer T, Jichi F, Manzur AY. Corticosteroids for the treatment of Duchenne muscular dystrophy. Cochrane Database Syst Rev. 2016;(5):CD003725. CD003725.pub4. https://doi.org/10.1002/14651858
  17. Petnikota H, Madhuri V, Gangadharan S, Agarwal I, Antonisamy B. Retrospective cohort study comparing the efficacy of prednisolone and deflazacort in children with muscular dystrophy: A 6 years’ experience in a South Indian teaching hospital. Indian J Orthop. 2016;50(5):551-557. https://doi.org/10.4103/0019-5413.189609
  18. Jacqueline M. The identification of Landouzy—Dejerine disease: an investigative history. Neuromuscul Disord. 2011;21(4):291-297. https://doi.org/10.1016/j.nmd.2011.01.003
  19. Belayew A. Cascade of gene activation in Landouzy Dejerine muscular dystrophy. Bull Mem Acad R Med Belg. 2010;165(1-2):87-95; discussion 95-97.
  20. Collins J, Bönnemann CG. Congenital muscular dystrophies: toward molecular therapeutic interventions. Curr Neurol Neurosci Rep. 2010;10(2):83-91. https://doi.org/10.1007/s11910-010-0092-8

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.